Evidence map›Paper›PMID 38068892›Full record

ArticleInternational journal of molecular sciences2023

PEGylation of Terminal Ligands as a Route to Decrease the Toxicity of Radiocontrast Re

Aleksei S Pronin, Tatiana N Pozmogova, Yuri A Vorotnikov, Georgy D Vavilov, Anton A Ivanov, Vadim V Yanshole, Alphiya R Tsygankova, Tatiana Ya Gusel'nikova, Yuri V Mironov, Michael A Shestopalov

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Aleksei S ProninNikolaev Institute of Inorganic Chemistry SB RAS, 3 Acad. Lavrentiev Ave., Novosibirsk 630090, Russia.ORCID 0000-0002-4663-3714
Tatiana N PozmogovaNikolaev Institute of Inorganic Chemistry SB RAS, 3 Acad. Lavrentiev Ave., Novosibirsk 630090, Russia.
Yuri A VorotnikovNikolaev Institute of Inorganic Chemistry SB RAS, 3 Acad. Lavrentiev Ave., Novosibirsk 630090, Russia.ORCID 0000-0002-7807-4697
Georgy D VavilovNational Medical Research Center for Circulation Pathology n.a. Academician E.N. Meshalkin, 15 Rechkunovskaya St., Novosibirsk 630055, Russia.ORCID 0000-0002-5951-3201
Anton A IvanovNikolaev Institute of Inorganic Chemistry SB RAS, 3 Acad. Lavrentiev Ave., Novosibirsk 630090, Russia.ORCID 0000-0003-2026-8568
Vadim V YansholeInternational Tomography Center SB RAS, 3a Institutskaya St., Novosibirsk 630090, Russia.ORCID 0000-0003-1512-3049
Alphiya R TsygankovaNikolaev Institute of Inorganic Chemistry SB RAS, 3 Acad. Lavrentiev Ave., Novosibirsk 630090, Russia.
Tatiana Ya Gusel'nikovaNikolaev Institute of Inorganic Chemistry SB RAS, 3 Acad. Lavrentiev Ave., Novosibirsk 630090, Russia.ORCID 0000-0003-3584-9074
Yuri V MironovNikolaev Institute of Inorganic Chemistry SB RAS, 3 Acad. Lavrentiev Ave., Novosibirsk 630090, Russia.ORCID 0000-0002-8559-3313
Michael A ShestopalovNikolaev Institute of Inorganic Chemistry SB RAS, 3 Acad. Lavrentiev Ave., Novosibirsk 630090, Russia.ORCID 0000-0001-9833-6060
Siberian Branch of the Russian Academy of Sciences · RUNovosibirsk State University · RUMeshalkin National Medical Research Center · RU

Funding

Council for Grants of the President of the Russian Federation MD-123.2022.1.3
6 · The paper itself

Abstract

The development of novel radiocontrast agents, mainly used for the visualization of blood vessels, is still an emerging task due to the variety of side effects of conventional X-ray contrast media. Recently, we have shown that octahedral chalcogenide rhenium clusters with phosphine ligands-Na

Indexed as

PeptidesProteinsAngiographyAnimalsContrast MediaLigandsMicePolyethylene GlycolsRatsContrast MediaLigandsPeptidesPolyethylene GlycolsProteinsacute toxicityangiographycomputed tomographycytotoxicityoctahedral chalcogenide rhenium clusterPEGylationphosphineX-ray contrast media

Identifiers

PMID38068892
PMCPMC10706756
OpenAlexW4388861067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.